US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19
U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of ...
又一個命運坎坷的抗新冠藥，氟伏沙明
美國監管機構拒絕清除用於治療 COVID-19 的廉價藥物的請求
提出請求的 David Boulware 博士說，FDA 犯了錯誤，因為它在分析氟伏沙明時使用的標準與分析主要製藥公司的藥物（例如輝瑞的藥丸）時使用的標準不同
https://m.theepochtimes.com/mkt_app/us-regulators-reject-request-to-clear-cheap-drug-for-treatment-of-covid-19_4474379.html
美國監管機構拒絕清除用於治療 COVID-19 的廉價藥物的請求
提出請求的 David Boulware 博士說，FDA 犯了錯誤，因為它在分析氟伏沙明時使用的標準與分析主要製藥公司的藥物（例如輝瑞的藥丸）時使用的標準不同
https://m.theepochtimes.com/mkt_app/us-regulators-reject-request-to-clear-cheap-drug-for-treatment-of-covid-19_4474379.html
https://m.theepochtimes.com/mkt_app/us-regulators-reject-request-to-clear-cheap-drug-for-treatment-of-covid-19_4474379.html
Past 31 days
Total Visit: 0
No response has been written yet. It is recommended to maintain a healthy skepticism towards it.
查謠言詐騙